Skip to main content

Control of Substrate Selectivity Through Complexation and Release of α-Chymotrypsin from Gold Nanoparticle Surfaces

Buy Article:

$113.00 plus tax (Refund Policy)

Abstract:

Mixed monolayer protected gold clusters (MMPCs) functionalized with mercaptoundecanoic acid (MUA) are efficient inhibitors of α-chymotrypsin (ChT). The binding of the ChT to MUA functionalized gold nanoparticles (MUA-AuNP) was found to denature the protein; however this complexation is reversible upon the addition of suitable positively charged surfactants. In this contribution we demonstrate that the released ChT has substrate selectivity differing from native ChT, with substrates featuring an extended peptide sequence completely inactive with the refolded enzyme. This alteration in activity provides a potential means for engineering substrate specificity, as well as providing a benchmark for correct refolding.

Keywords: ALPHA-CHYMOTRYPSIN; GOLD NANOPARTICLES; MMPCS; PROTEIN ACTIVITY; PROTEINS; SUBSTRATE SELECTIVITY

Document Type: Research Article

DOI: https://doi.org/10.1166/jbn.2005.037

Publication date: 2005-09-01

More about this publication?
  • Journal of Biomedical Nanotechnology (JBN) is a peer-reviewed multidisciplinary journal providing broad coverage in all research areas focused on the applications of nanotechnology in medicine, drug delivery systems, infectious disease, biomedical sciences, biotechnology, and all other related fields of life sciences.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more